Study of Recombinant Human Endostatin Combined With CV Regimen in the Treatment of Pediatric Low-grade Gliomas
Clinical trial NCT04659421 · COMPLETED
Trial details
- NCT number
- NCT04659421
- Sponsor
- Beijing Sanbo Brain Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-03
- Primary completion
- 2023-07-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.